Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07641608

Investigation of Chemical Stability and Sterility of Morphine in Intrathecal Pumps for Long-Term Pain Management

Intrathecal drug delivery systems (IDDS) are effective for managing chronic pain by delivering medications directly into the cerebrospinal fluid. Morphine, a primary opioid used in these systems, must remain chemically stable and sterile over prolonged periods to ensure patient safety and therapeutic efficacy . Previous studies have evaluated morphine stability in vitro under simulated conditions , indicating minimal degradation in saline over time . However, there is limited real-world data regarding the residual morphine in pump reservoirs after extended use . This study seeks to bridge this gap by analyzing morphine aspirated from intrathecal pumps during routine refills in a clinical setting, while comparing it to in vitro samples taken in the clinic .. Objectives Primary Objective: To determine the chemical stability of morphine in intrathecal pump reservoirs over a 3 to 6-month period of clinical use.

Secondary Objective: To assess the sterility of residual morphine and evaluate any microbial contamination.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Meir Medical Center

Kfar Saba, Israel

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

• Adult patients (age ≥ 18 years), Diagnosed with chronic pain and currently treated with an implantable intrathecal pump.

  • Receiving intrathecal Morphine (Rafa Laboratories, 20 mg/ml; registration no. 106-25-28981-00).
  • Scheduled for a routine pump refill procedure at an interval of 3 to 6 months.

Exclusion criteria

• Patients receiving polyanalgesic mixtures (admixtures of morphine with other drugs) in the intrathecal pump.

  • Evidence of active systemic infection or localized infection at the pump implantation site.
  • History of recent pump malfunction or refills occurring outside the standard 3 to 6-month window.
  • Inability to provide informed consent.
  • Pregnant patients.

Treatment and study plan

Culturing and testing chemical stability

Diagnostic Test

Culturing and testing chemical stability

Primary outcomes

  1. Rate of positive bacterial culture

    Time frame: 1 week

    Rate of positive bacterial culture from morphine aspirate

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Official study title

Morphine in Intrathecal Pumps for Long-Term Pain Management

Important dates

Study start
2027
Primary completion
2028
Study completion
2028
First posted
Jun 11, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.